ELC GROUP

ELC GROUP | January 24, 2017

Global life sciences partner ELC Group is teaming with New Zealand-based research and development company Pharma Scientific Research (PSR Group) to create highly advanced products for the pharmaceutical market....

ELC GROUP | March 02, 2017

The procedure places generic, biosimilar and value-added medicines at the heart of the debate on access to medicines. Specifically, the report calls for Member States to encourage competition from generic and biosimilar medicines by removing barriers and adopting uptake measures....

Pharmacy Business | January 14, 2020

The government on Monday announced a collaboration with Novartis to launch a clinical trial for ‘yet to be approved’ drug inclisiran. The drug could benefit thousands of patients at risk of heart disease in coming years. The ground-breaking collaboration includes Novartis, NHS England and the National Institute for Health Research (NIHR) and Oxford University. The Department of Health and Social Care (DHSC) expects this to position the UK as a world-leading destination to develop cut...

Business Wire Press Releases | January 16, 2020

Today announced it has signed a long-term agreement with Thermo Fisher Scientific to develop and manufacture medications with Civica as the owner of the regulatory pathway. By working with Thermo Fisher to develop Civica-owned Abbreviated New Drug Applications (ANDAs), Civica will secure the manufacture of certain essential medications, further mitigating the risk of drug shortages in the future. This partnership has an initial seven-year term and represents a key component of Civica’s man...